| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $249.4M | +43.1% |
| Cost of Revenue | $1.0M | -4.8% |
| R&D Expense | $163.5M | +60.5% |
| SG&A Expense | $144.5M | +17.4% |
| Operating Income | -$59.6M | -15.4% |
| Interest Expense | $5.2M | -4.7% |
| Pre-tax Income | -$60.9M | -48.9% |
| Income Tax | -$5.6M | -148.1% |
| Net Income | -$55.3M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $442.6M | +10.0% |
| Accounts Receivable | $52.1M | +55.1% |
| Inventory | $4.5M | +550.4% |
| Current Assets | $528.8M | +11.6% |
| Total Assets | $597.0M | +13.3% |
| Current Liabilities | $139.0M | +37.9% |
| Total Liabilities | $228.2M | +21.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.9M | +106.0% |
| Capital Expenditures | $5.4M | +146.3% |
| Investing Cash Flow | -$5.4M | -146.9% |
| Financing Cash Flow | $34.3M | -76.4% |
| Free Cash Flow | -$2.5M | +95.2% |
| -5.2% |
| EPS (Basic) | -$1.13 | +1.7% |
| EPS (Diluted) | -$1.13 | +1.7% |
| Stockholders' Equity |
| $368.8M |
| +8.8% |